scholarly journals Facial Diplegia: A Rare, Atypical Variant of Guillain-Barré Syndrome and Ad26.COV2.S Vaccine

Cureus ◽  
2021 ◽  
Author(s):  
Esha Jain ◽  
Krunal Pandav ◽  
Pratima Regmi ◽  
George Michel ◽  
Ida Altshuler
Keyword(s):  
Guillain Barre Syndrome ◽  
Facial Diplegia ◽  
Guillain Barré Syndrome ◽  
Guillain Barré ◽  
Atypical Variant

scholarly journals Isolated facial diplegia: A rare presentation of Guillain‐Barre syndrome

2021 ◽  
Vol 9 (7) ◽  
Author(s):  
Sundus Sardar ◽  
Sreethish Sasi ◽  
Suresh Menik Arachchige ◽  
Muhammad Zahid ◽  
Gayane Melikyan
Keyword(s):  
Guillain Barre Syndrome ◽  
Rare Presentation ◽  
Facial Diplegia ◽  
Guillain Barré Syndrome ◽  
Guillain Barré

Facial Diplegia, Guillain-Barré Syndrome

2015 ◽  
pp. 1-2
Author(s):  
Jason E. Hale ◽  
Sumayya J. Almarzouqi ◽  
Andrew G. Lee ◽  
Michael L. Morgan
Keyword(s):  
Guillain Barre Syndrome ◽  
Facial Diplegia ◽  
Guillain Barré Syndrome ◽  
Guillain Barré

When is facial diplegia regarded as a variant of Guillain-Barré syndrome?

2015 ◽  
Vol 20 (1) ◽  
pp. 32-36 ◽  
Author(s):  
J. K. Kim ◽  
S. Y. Oh ◽  
E. H. Sohn ◽  
Y. H. Hong ◽  
S. M. Jun ◽  
...  
Keyword(s):  
Guillain Barre Syndrome ◽  
Facial Diplegia ◽  
Guillain Barré Syndrome ◽  
Guillain Barré

scholarly journals Miller-Fisher Syndrome and Guillain-Barre Syndrome overlap syndrome in a patient post Oxford-AstraZeneca SARS-CoV-2 vaccination

2021 ◽  
Vol 14 (11) ◽  
pp. e246701
Author(s):  
Yew Li Dang ◽  
Alexander Bryson
Keyword(s):  
Overlap Syndrome ◽  
Miller Fisher Syndrome ◽  
Guillain Barre Syndrome ◽  
Oculomotor Nerve Palsy ◽  
Limb Weakness ◽  
Patient Counselling ◽  
Fisher Syndrome ◽  
Facial Diplegia ◽  
Guillain Barré Syndrome ◽  
Guillain Barré

We describe a patient who developed bilateral oculomotor nerve palsy, ataxia, facial diplegia and lower limb weakness 2 weeks post-Oxford-AstraZeneca SARS-CoV2 vaccination, consistent with Miller-Fisher syndrome (MFS) and Guillain-Barre syndrome (GBS) overlap syndrome. Although some features of the patient’s presentation were typical of recently reported cases of a rare GBS variant post-Oxford-AstraZeneca vaccination, including severe facial weakness and a lack of respiratory involvement, to our knowledge this is the first reported case of MFS associated with SARS-CoV2 vaccination. While postvaccination GBS remains rare, it appears to have a favourable prognosis, and recognising this entity is therefore important for patient counselling and monitoring for potential complications.

Sign in / Sign up

Export Citation Format

Share Document